IRB Discussion Consent and Assent Issues in Vulnerable Populations December 2008 612-626-5922.

Slides:



Advertisements
Similar presentations
Chapter 3: Ethical Issues in Health Promotion Research
Advertisements

Children as Human Research Subjects Subpart D A Presentation for IRB Members.
ETHICS OF CONSENTING IMPAIRED INDIVIDUALS THERAPEUTICS Col Xolani Currie, Nat Dipl Rad, BA, HED, MPH Regulatory Oversight Manager Project Phidisa.
VA Requirements for Vulnerable Subjects Kevin L. Nellis, M.S., M.T. (A.S.C.P.) Program Analyst Program for Research Integrity Development and Education.
© HRP Associates, Inc. Informed Consent, Parental Permission & Assent Jeffrey M. Cohen, Ph.D., CIP President, HRP Associates, Inc.
Top Ten Investigator Responsibilities When Conducting Human Subjects Research Thanks to Ada Sue Selwitz, Univ. of Kentucky and PRIM&R (Public Responsibility.
By: Ronald F. White, Ph.D. Professor of Philosophy College of Mount St. Joseph.
Human Subjects & Research Understanding the protection of human subjects, HSRC, and the nature of the process.
UH employees and students who conduct research involving human subjects are required to obtain approval from the Committee on Human Studies (CHS). John.
THE ETHICS OF HUMAN PARTICIPANT RESEARCH Office for Research Protections The Pennsylvania State University.
Pediatric Ethics Subcommittee of Pediatric Advisory Committee, September 10, 2004 Analysis of Research Protocols Involving Children: Combining Subparts.
IRB BASICS: Ethics and Human Subject Protections
CUMC IRB Investigator Meeting Special IND/IDE Considerations: Emergency Use of Investigational Product Compassionate Use & Emergency Research July 21,
Ethical Guidelines for Research with Human Participants
Detectives in the Classroom - Investigation 2-3: What's Wrong with This Picture? What's Wrong with This Picture?
© HRP Associates, Inc. Ethics & Regulation of Human Subjects Research Jeffrey M. Cohen, Ph.D., CIP President, HRP Associates, Inc.
8 Criteria for IRB Approval of Research 45 CFR (a)
Introduction. Research with Minors A Harvard Longwood QIP Education Session Matthew Stafford Assistant Director, Clinical Research Compliance.
FOUNDATIONS OF NURSING RESEARCH Sixth Edition CHAPTER Copyright ©2012 by Pearson Education, Inc. All rights reserved. Foundations of Nursing Research,
Ethical Principles of Human Subjects Protection
DO THE CODES APPLY TO MY RESEARCH?
Human Subject Research Ethics
1 Wheaton College INSTITUTIONAL REVIEW BOARD (IRB)
A History of Human Research Protections and Institutional Review Boards Roger L. Bertholf, Ph.D. Associate Professor of Pathology Chair, University of.
The Goals and Principles of Human Participant Protection Part 4: Vulnerable Populations.
Overview of Research Oversight: U.S. Perspective Leslie K. Ball, M.D., F.A.A.P. Office for Human Research Protections Department of Health and Human Services.
Research with Vulnerable Populations Marisue Cody, PhD, RN IRB Chair Training Washington DC, April 9, 2004.
INSTITUTIONAL REVIEW BOARD HISTORY AND ETHICS. 2 Ethical History : Holocaust : Nuremburg Trials 1964: Declaration of Helsinki :
HUMAN RESEARCH HISTORICAL PERSPECTIVE. Objectives Identify the history events that lead to the development of principles, regulations, and guidance.
Human Research Protection Program 101 July 19-20, 2007 Milwaukee, WI.
1 Protection of Vulnerable Subjects in Research Melody Lin, Ph.D. December 2012.
The Institutional Review Board: A Community College Toolkit Dr. Geri J Anderson.
IRB BASICS: Issues in Ethics and Human Subject Protections Prepared by Ed Merrill Department of Psychology November 12, 2009.
Institutional Review Board (IRB) What is our Purpose and Role for Ethical Research.
TERRENCE F. ACKERMAN, PH.D. PROFESSOR OF BIOETHICS CHAIR, UTHSC IRB.
The ethical conduct of research with human participants Nancy E. Kass, ScD Department of Health Policy and Management Johns Hopkins Berman Institute of.
Human Subject Protection Research Imperatives. History World War II - Nuremberg Tuskegee Study Belmont Report Modern Problems - Inadequacy of “Good Intentions”
Protecting Children in Cancer Research: What Really Matters Eric Kodish, M.D. Rainbow Center for Pediatric Ethics Rainbow Babies and Childrens Hospital.
Research Ethics.
Ethics Ethics Applied to Research Back to Class 2.
The Ethics of Research on Human Subjects. Research Activity on Human Subjects: Any systematic attempt to gain generalizable knowledge about humans A systematic.
Unless otherwise noted, the content of this course material is licensed under a Creative Commons 3.0 License.
NAVIGATING THE IRB PROCESS University Institutional Review Board California State University, Stanislaus.
TUN IRB: The Basics February 26, IRB Function Review human-subject research Ensure the rights & welfare of human subjects are adequately protected.
What Institutional Researchers Should Know about the IRB Susan Thompson Senior Research Analyst Office of Institutional Research Presented at the Texas.
Challenges of 21st Century Clinical Research from an Independent IRB’s View Chesapeake Research Review, Inc. Paul Goebel, CIP Vice President Matthew Whalen,
Regulatory requirements: children, assent, and consent waivers and waiver of documentation Bob Craig, 2007.
Chapter 10 Research in the Schools: Ethical-Legal Issues Jacob, Decker, & Hartshorne 1.
Chapter 5 Ethical Concerns in Research. Historical Perspective on Ethics Nazi Experimentation in WWII –“medical experiments” –Nuremberg War Crime Trials.
Pediatric Research Ethics and the Research Subject Advocate Tomas Jose Silber, MD, MASS RSA and Director, Office of Ethics, CNMC Professor of Pediatrics,
Ann Billetz, Ph.D. 11/6/09. Excerpt from MCLA’s IRB policy.
Medical Research in Times of Bioterrorism - OHRP’s Perspective Michael A. Carome, M.D. Associate Director for Regulatory Affairs Office for Human Research.
Legal Responsibilities for Studies Conducted or Supported by HHS Michael A. Carome, M.D. Associate Director for Regulatory Affairs Office for Human Research.
Principles for the Protection of Human Rights Beneficence Primary goal of health care as doing good for clients under our care. Good care requires that.
Doing IRB Right … Together JOHN POTTER, OD, MA Chair, Institutional Review Board.
Protecting Human Subjects Overview of the Issues Applications to Educational Research The IRB Process.
Back to Basics – Approval Criteria
To start the presentation, click on this button in the lower right corner of your screen. The presentation will begin after the screen changes and you.
Class 9 Jeff Driskell, MSW, PhD
Children in Research: They’re Not Just Small Adults
Risk Determinations and Research with Children
Jeffrey M. Cohen, Ph.D. CIP President HRP Associates, Inc.
IRB BASICS: Ethics and Human Subject Protections
Overview of Important Changes to the Final Rule
Children as Subjects – Important Ethical and Logistical Considerations
Intro to Projects – Research with Human Subjects
Greg Nezat CRNA, PhD CDR/NC/USN Chairman, IRB II
Ethics Review Morals: Rules that define what is right and wrong Ethics: process of examining moral standards and looking at how we should interpret and.
Ethics of human research
Presentation transcript:

IRB Discussion Consent and Assent Issues in Vulnerable Populations December

History of Research Using Vulnerable Populations Nazi Experiments with Jewish and mentally ill inmates Nazi Experiments with Jewish and mentally ill inmates Willowbrook trials with institutionalized children with mental retardation Willowbrook trials with institutionalized children with mental retardation Tuskegee syphilis study of poor and poorly educated African American men Tuskegee syphilis study of poor and poorly educated African American men

The Nuremberg Code (1947) As part of the verdict, the Court enumerated some rules for "Permissible Medical Experiments", now known as the “Nuremberg Code”. These ten rules include: Voluntary consent Voluntary consent Yield fruitful results otherwise unobtainable Yield fruitful results otherwise unobtainable Based on animal experiments Based on animal experiments Avoid physical and mental suffering Avoid physical and mental suffering Not done if injury expected Not done if injury expected Risk less than importance of problem Risk less than importance of problem Protect subject from injury Protect subject from injury Conducted by qualified people Conducted by qualified people Termination by subject Termination by subject Termination by investigator Termination by investigator

Principle 1 The voluntary consent of the human subject is absolutely essential. This means that the person involved should have legal capacity to give consent; should be so situated as to be able to exercise free power of choice without the intervention of any element of force, fraud, deceit, duress, over- reaching or other ulterior form of constraint or coercion; and should have sufficient knowledge and comprehension of the elements of the subject matter involved as to enable him to make an understanding and enlightened decision.

The Belmont Report Ethical Principles and Guidelines for the Protection of Human Subjects of Research The National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research April 18, 1979

The Belmont Report Basic Ethical Principles: Respect for Persons Respect for Persons –Individual autonomy –Protection of individuals with reduced autonomy Beneficence Beneficence –Maximize benefits and minimize harms –Do good, not just avoid harm Justice Justice –Equitable distribution of research costs and benefits

45 CFR 46 – DHHS Policy for Protection of Human Research Subjects- Subpart A Originally adopted January 13, 1981 Revised June 18, 1991 “The Common Rule” –Federal Policy for Protection of Human Subjects, June 18, 1991 –adopted by 17 federal agencies

Federal Regulations and Policy Additional Protections Included in 45 CFR 46: Subpart B- Additional DHHS Protections Pertaining to Research, development, and Related Activities Involving Pregnant Women, Fetuses, and Neonates (non-viable and those of uncertain viability) Subpart C- Additional DHHS Protections Pertaining to Biomedical and Behavioral Research Involving Prisoners as Subjects Subpart D- Additional DHHS Protections for Children Involved as Subjects in Research

Authority: –Federal Food, Drug, and Cosmetic Act (1962) Regulations: –IRB: 21 CFR 56 –Informed Consent: 21 CFR 50  Adopted Sub Part D --- April 2001 –Investigational Drugs: 21 CFR 312 –Investigational Devices: 21 CFR 812

Inclusion of children: 45 CFR 46 Subpart D 21 CFR 50 Subpart D Guidelines expand inclusion requirements Guidelines expand inclusion requirements Exclusion must be justified Exclusion must be justified Guidelines do not relax requirement of benefit Guidelines do not relax requirement of benefit Issues of parental permission and child assent present challenges Issues of parental permission and child assent present challenges

Federal Regulations: Children Category Requirements 45 CFR CFR Minimal risk Parental Permission Child’s assent

Federal Regulations: Children Category Requirements 45 CFR CFR Greater than minimal risk; direct benefit Greater than minimal risk; direct benefit Risk justified by benefit Risk justified by benefit Risk/benefit is as favorable as the alternative Risk/benefit is as favorable as the alternative Parental permission Parental permission Child’s assent/as required by IRB Child’s assent/as required by IRB

Federal Regulations: Children Category Requirements 45 CFR CFR Greater than minimal risk/ no direct benefit/ will yield generalizable knowledge Minor increase over minimal risk Experiences commensurate with inherent, actual, or expected situations Yield knowledge of vital importance Both parents give permission Child assent

Federal Regulations: Children Category Requirements 45 CFR CFR Federal Regulations: Children Category Requirements 45 CFR CFR Otherwise not approvable opportunity to understand, prevent or alleviate serious problem affecting children HHS/FDA consultation panel of experts Public comment

Assent Affirmative agreement: failure to object is not assentAffirmative agreement: failure to object is not assent Required except whenRequired except when child not capable; age, maturity, psychological statechild not capable; age, maturity, psychological state research presents direct benefit, important to child’s well being and available only in context of researchresearch presents direct benefit, important to child’s well being and available only in context of research Age not specified in regulations IRB determines whether and how to document

IRBs give special consideration to populations not protected with specific regulatory sub parts: Vulnerable Subjects (regs take group approach): Vulnerable Subjects (regs take group approach): –decisionally impaired including persons with physical handicaps and mental disabilities –economically disadvantaged persons –educationally disadvantaged persons

Other considerations when defining “Vulnerable”: Language Language Culture Culture Current Events or Incidents Current Events or Incidents Age (elderly) Age (elderly) Age (adolescents) Age (adolescents) Transient Cognitive Impairment Transient Cognitive Impairment Chemical Use Chemical Use Health Status Health Status

IRB also understands Definition of vulnerable is not black and white Definition of vulnerable is not black and white People can go in and out of vulnerability People can go in and out of vulnerability Regulations are vague on this issue. Regulations are vague on this issue. Bottom Line: The IRB must ensure that there are additional safeguards to protect the rights and welfare of these participants Bottom Line: The IRB must ensure that there are additional safeguards to protect the rights and welfare of these participants

Targeting/Including Vulnerable Populations; Appendix I Though not specifically referenced in the federal regulations, the targeting or inclusion of potentially vulnerable populations (other than children, pregnant women/fetuses and prisoners) in research requires special considerations Though not specifically referenced in the federal regulations, the targeting or inclusion of potentially vulnerable populations (other than children, pregnant women/fetuses and prisoners) in research requires special considerations

Appendix I of IRB Application Mentally/Emotionally/Developmentally Disabled/Impaired Decision Making Capacity TargetedIncluded TargetedIncluded Provide justification Provide justification Explain how competency to provide consent will be determined and plan for obtaining surrogate consent Explain how competency to provide consent will be determined and plan for obtaining surrogate consent

How to consent Combination of “permission” from a legally authorized representative and the “assent” of potential participants Combination of “permission” from a legally authorized representative and the “assent” of potential participants Witnesses to consent process Witnesses to consent process Periodic “re-consent” Periodic “re-consent” Formal checks of comprehension Formal checks of comprehension

Legally Authorized Representative..an individual, or judicial or other body, under applicable law to consent on behalf of the prospective subject to the subject’s participation in the procedures involved in the research. 45 CFR (c) and 21 CFR 50.3 (25) (l)

For Further information: UMN RSPP Office: UMN IRB Web Site:

Questions ?